The latest closing stock price for SpringWorks Therapeutics as of September 19, 2024 is 35.35.
An investor who bought $1,000 worth of SpringWorks Therapeutics stock at the IPO in 2019 would have $562 today, roughly 1 times their original investment - a 9.33% compound annual growth rate over 5 years.
The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
The SpringWorks Therapeutics 52-week high stock price is 53.92, which is 52.5% above the current share price.
The SpringWorks Therapeutics 52-week low stock price is 18.00, which is 49.1% below the current share price.
The average SpringWorks Therapeutics stock price for the last 52 weeks is 37.74.
An investor who bought $1,000 worth of SpringWorks Therapeutics stock at the IPO in 2019 would have $562 today, roughly 1 times their original investment - a 9.33% compound annual growth rate over 5 years.
The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
The SpringWorks Therapeutics 52-week high stock price is 53.92, which is 52.5% above the current share price.
The SpringWorks Therapeutics 52-week low stock price is 18.00, which is 49.1% below the current share price.
The average SpringWorks Therapeutics stock price for the last 52 weeks is 37.74.